anmelden
FTSE All-Share
5.479,78
PKT
-90,59
PKT
-1,63
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.11.17 | Glencore Neutral | JP Morgan Chase & Co. | |
| 02.11.17 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 02.11.17 | Prudential buy | Citigroup Corp. | |
| 02.11.17 | National Grid neutral | Barclays Capital | |
| 02.11.17 | GSK buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.11.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 01.11.17 | BP Hold | Kepler Cheuvreux | |
| 01.11.17 | AstraZeneca buy | Kepler Cheuvreux | |
| 01.11.17 | BP Neutral | Citigroup Corp. | |
| 01.11.17 | Sky buy | Citigroup Corp. | |
| 01.11.17 | AstraZeneca buy | Deutsche Bank AG | |
| 01.11.17 | BP buy | Deutsche Bank AG | |
| 01.11.17 | BP buy | UBS AG | |
| 01.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 01.11.17 | Diageo overweight | JP Morgan Chase & Co. | |
| 01.11.17 | BP overweight | JP Morgan Chase & Co. | |
| 01.11.17 | Barclays overweight | JP Morgan Chase & Co. | |
| 01.11.17 | AstraZeneca Reduce | HSBC | |
| 01.11.17 | BP buy | HSBC | |
| 01.11.17 | BP Neutral | Goldman Sachs Group Inc. | |
| 31.10.17 | BP Sector Perform | RBC Capital Markets | |
| 31.10.17 | HSBC Hold | Deutsche Bank AG | |
| 31.10.17 | Glencore Outperform | Macquarie Research | |
| 31.10.17 | BP Hold | S&P Capital IQ | |
| 31.10.17 | HSBC Neutral | JP Morgan Chase & Co. | |
| 31.10.17 | GSK buy | Jefferies & Company Inc. | |
| 31.10.17 | HSBC Equal weight | Barclays Capital | |
| 30.10.17 | National Grid Sell | Deutsche Bank AG | |
| 30.10.17 | HSBC Neutral | Goldman Sachs Group Inc. | |
| 30.10.17 | HSBC Neutral | UBS AG | |
| 27.10.17 | GSK Underweight | Morgan Stanley | |
| 27.10.17 | Barclays overweight | Morgan Stanley | |
| 27.10.17 | BAT buy | Deutsche Bank AG | |
| 27.10.17 | GSK Hold | Deutsche Bank AG | |
| 27.10.17 | GSK Sell | Société Générale Group S.A. (SG) | |
| 27.10.17 | Barclays buy | Société Générale Group S.A. (SG) | |
| 27.10.17 | Vodafone Group buy | UBS AG | |
| 27.10.17 | Barclays Sell | Goldman Sachs Group Inc. | |
| 27.10.17 | GSK buy | Goldman Sachs Group Inc. | |
| 27.10.17 | GSK Equal weight | Barclays Capital |